Advertisements

Escitalopram Heumann

Quick links to important sections

Medically reviewed

Rosario Oropesa

Last updated on 22/12/2025

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Advertisements

Overview of Escitalopram Heumann

What is Escitalopram Heumann?

Escitalopram Heumann is a pharmaceutical medication belonging to a class of drugs known as selective serotonin reuptake inhibitors, often abbreviated as SSRIs. It contains the active substance escitalopram, which is used to manage specific mental health conditions by affecting chemical messengers in the brain.

Mechanism of Action

The human brain utilizes various neurotransmitters to regulate mood and emotional stability. Serotonin is one such neurotransmitter. In individuals experiencing certain psychological conditions, the balance of serotonin may be disrupted. Escitalopram works by inhibiting the reabsorption (reuptake) of serotonin into the nerve cells. This process increases the concentration of available serotonin in the synaptic cleft—the space between neurons—thereby enhancing neurotransmission and helping to stabilize mood.

Clinical Applications

Escitalopram Heumann is primarily used for the treatment of major depressive episodes. Beyond depression, it is also indicated for several anxiety-related disorders, including:

  • Panic disorder: Characterized by sudden attacks of intense fear, with or without agoraphobia.
  • Social anxiety disorder: Also known as social phobia, involving significant fear or anxiety in social situations.
  • Generalized anxiety disorder (GAD): Involving persistent and excessive worry about various activities or events.
  • Obsessive-compulsive disorder (OCD): Characterized by repetitive, unwanted thoughts and behaviors.

As an SSRI, it is designed to provide a targeted effect on the serotonin system, distinguishing it from older generations of antidepressants that may affect a broader range of neurotransmitters.

Regulatory References

  1. NIH - Escitalopram Information
  2. MedlinePlus - Escitalopram Drug Information
Advertisements

What side effects are possible with Escitalopram Heumann?

Possible Side Effects and Safety Information

This section summarizes the officially documented adverse reactions and safety information for Escitalopram Heumann, based on authoritative governmental regulatory documents.


Frequency-Classified Adverse Reactions

Adverse reactions are organized by how frequently they are observed, based on regulatory data:

  • Very Common (Affects 1 in 10 or more people): Nausea, Headache.
  • Common (Affects 1 to 10 in 100 people): Insomnia, Somnolence (drowsiness), Diarrhoea, Constipation, Dry mouth, Increased sweating, Decreased libido, Ejaculation disorder, Impotence, Anorgasmia, Fatigue.
  • Uncommon (Affects 1 to 10 in 1,000 people): Tachycardia (rapid heartbeat), Gastrointestinal haemorrhages, Urticaria (hives), Alopecia (hair loss).

Serious Adverse Reactions and Safety Concerns

Regulatory documents highlight rare but clinically important reactions and safety concerns:

  • Serotonin Syndrome: A potentially serious reaction, often associated with combining Escitalopram with other serotonergic medicines.
  • Cardiac Risks: Documentation includes the risk of QT-interval prolongation and Ventricular Arrhythmia, which can affect heart rhythm.
  • Suicidal Thoughts and Behaviour: The label notes the risk of suicidal ideation, particularly during the initial months of therapy or following dose adjustments.
  • Hyponatraemia: A risk of dangerously low sodium levels in the blood, noted especially in older adults.
  • Abnormal Bleeding: Increased risk of bleeding events, including gastrointestinal haemorrhage and postpartum haemorrhage.

Population-Specific and Time-Related Safety

  • Pediatric Use: Official warnings exist concerning the risk of suicidal thoughts and behaviours in children and adolescents.
  • Older Adults: Increased monitoring is suggested due to the higher risk of Hyponatraemia.
  • Time Pattern: Side effects are generally most frequent and intense during the first two weeks of treatment and tend to lessen with continued use. Abrupt cessation is associated with discontinuation symptoms.

Safety Restrictions

Escitalopram is contraindicated (should not be used) with certain medications, including Monoamine Oxidase Inhibitors (MAOIs), or in patients with known pre-existing QT-interval prolongation or congenital long QT syndrome.

Advertisements

Overdose and Emergency Response

The official regulatory profile for Escitalopram overdose is defined by documented systemic and cardiac risks. Overdose manifestations commonly affect the Central Nervous System, presenting as drowsiness, confusion, agitation, and tremor, alongside gastrointestinal effects like nausea and vomiting. Tachycardia and hypotension are also documented findings.

A primary severe, life-threatening outcome associated with overdose is Serotonin Syndrome, which is characterized by confusion, fever, and neuromuscular abnormalities. Furthermore, large ingestions carry a specific cardiovascular risk, notably QTc interval prolongation on an ECG, which can lead to the severe cardiac arrhythmia Torsades de Pointes.

Regulatory guidance mandates that individuals must seek immediate medical attention for any suspected overdose or if any symptoms progress beyond mild effects. Treatment is strictly symptomatic and supportive, as no specific antidote is known. Hospital monitoring is required, including continuous cardiac observation for patients with QTc abnormalities or after substantial ingestion. The complexity and potential severity of overdose are officially noted to be increased by the co-ingestion of other serotonergic substances.

Advertisements

Therapeutic Uses of Escitalopram Heumann

What Escitalopram Heumann Treats: Main Uses and Benefits

Escitalopram Heumann is commonly used across domains where additional symptomatic support is needed for symptom-focused domains related to mood and anxiety. It is relevant in contexts marked by increased discomfort or tension. This medicine is applied in addressing core symptom patterns across several therapeutic domains, including Major Depressive Disorder (MDD), Generalized Anxiety Disorder (GAD), Panic Disorder (PD), Social Anxiety Disorder (SAD), and Obsessive-Compulsive Disorder (OCD). The supportive role may assist with easing the overall symptom burden.

The medication is relevant for easing symptoms in conditions characterized by periods of heightened symptoms. It is applied in addressing symptoms such as persistent sadness, loss of interest, excessive worry, and intrusive thoughts. In these clinical scenarios, which often involve symptoms that create noticeable functional strain, it assists with maintaining functional stability and contributes to improved comfort during symptomatic periods.

“It may help patients cope more steadily with symptom fluctuations, supports the patient during difficult episodes by easing distress and contributes to improved comfort during symptomatic periods.”


Quick Fact: Relevant for Easing Symptoms of Chronic Worry and Anxiety Escitalopram is considered relevant for easing the cognitive and physical symptoms associated with excessive apprehension and fear-driven avoidance.


Regulatory References

  1. NIH MedlinePlus overview
Advertisements

Eligibility and Restrictions for Use

Who can and cannot use Escitalopram Heumann?

This medicine's eligibility is strictly defined by regulatory body documentation, focusing on absolute contraindications and specific population limitations.

Classification Population/Condition Regulatory Status
Absolute Contraindication Known hypersensitivity to escitalopram, citalopram, or excipients. Must Not Use
Concomitant use with MAOIs (including Linezolid) or Pimozide. Must Not Use
Known QT interval prolongation or congenital long QT syndrome (European/Canadian label). Must Not Use
Age Eligibility Adults (ge 18 years) for all labeled uses. Allowed
Adolescents (12–17 years) for Major Depressive Disorder (MDD). Allowed (FDA)
Children under 12 for MDD; under 7 for Generalized Anxiety Disorder (GAD). Use Not Established
Conditional Use Older Adults (ge 65 years); patients with Hepatic Impairment. Caution Required (Lower max dose may be advised)
Patients with Severe Renal Impairment or unstable epilepsy. Caution Required
Reproductive Status Pregnancy; Lactation (Breastfeeding). Caution Required (Benefit vs. Risk must be weighed)

Eligibility is limited for specific populations due to reduced drug clearance or safety profile considerations, such as in older adults and individuals with hepatic impairment. The official label specifies that use must be discontinued if a patient develops new seizures or enters a manic phase.

Advertisements

What should I know about interactions with other medicines?

Interactions with other medicines and products

Contraindicated Combinations

Escitalopram Heumann must not be used with certain other medicines, as the combination carries a high risk of serious adverse effects. The most critical combinations to avoid are:

  • Monoamine Oxidase Inhibitors (MAOIs): Including non-selective MAOIs (e.g., phenelzine, tranylcypromine), the reversible MAO-A inhibitor moclobemide, and non-selective reversible inhibitors like linezolid and intravenous methylene blue. This combination is associated with a severe risk of Serotonin Syndrome. A washout period of at least 14 days is required when switching from an irreversible MAOI to escitalopram, and 7 days when switching from escitalopram to an MAOI.
  • QT-prolonging medicines: Concomitant use with medicinal products known to prolong the QT interval (e.g., certain antipsychotics, antiarrhythmics) is contraindicated due to the risk of life-threatening heart rhythm issues, such as Torsade de Pointes.

Use with Caution

  • Serotonergic products: Other medicines that increase serotonin levels, such as triptans (for migraine), tramadol, tryptophan, and St. John's Wort, must be used with caution due to the heightened risk of Serotonin Syndrome.
  • Medicines affecting haemostasis: Concomitant use with oral anticoagulants (e.g., warfarin), Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) like ibuprofen and naproxen, and aspirin increases the risk of abnormal bleeding or haemorrhage. Close monitoring of coagulation is required for patients taking warfarin.
  • CYP2D6 Substrates: Escitalopram is a moderate inhibitor of the CYP2D6 enzyme, which may lead to increased blood concentrations of co-administered drugs primarily metabolized by this enzyme (e.g., certain tricyclic antidepressants, antipsychotics, and beta-blockers). Dose adjustments may be necessary.
Advertisements

Mechanism of Action

Selective Blockade of the Serotonin Transporter ( SERT)

The drug's primary action is the selective inhibition of the Serotonin Transporter ( SERT) protein on presynaptic nerve cells. This molecular interaction prevents the reabsorption of the neurotransmitter serotonin ( 5-HT), which immediately increases the concentration of 5-HT available in the synaptic cleft. The mechanism is specific to the serotonergic pathway; the drug’s single S-enantiomer structure facilitates binding to both the orthosteric and allosteric sites on the transporter.

Time-Dependent Neuroadaptive Modulation

The sustained increase in 5-HT concentration initiates a neuroadaptive cascade within the Central Nervous System (CNS). Over a period of weeks, this enhanced signaling leads to the gradual desensitization of presynaptic mathbf5-HT1A autoreceptors, functionally removing the inhibitory brake on 5-HT release. This physiological change amplifies the functional serotonergic signal, leading to the long-term modulation of CNS circuits involved in regulating affective state.

Advertisements

Dosage and Administration Information

How to Use Escitalopram Heumann: Official Administration Guidelines

Escitalopram Heumann is administered orally (by mouth) and is taken once daily. The tablet may be taken either in the morning or the evening, with or without food.

Official Dosing and Age-Group Rules

The medicine is typically started at a recommended dose, which may then be adjusted according to official medical guidelines. Any dose increase should occur only after a specified time period, such as at least one week after the initial adult dose is started.

Patient Group Initial Recommended Dose Maximum Daily Dose
Adults (General) 10 mg once daily 20 mg
Elderly Patients (over 65) 10 mg once daily 10 mg
Patients with Liver Impairment 10 mg once daily 10 mg
Adolescents (12+ years) 10 mg once daily 20 mg

Procedural and Discontinuation Rules

The administration requires no special preparation steps, such as dilution or shaking. To ensure standardized use, the full course of treatment should adhere to the initial dose, the time-frame for any increases, and the maximum allowed dose for the individual's specific group.

Stopping Treatment: When treatment with Escitalopram Heumann is to be stopped, it is recommended that the dose be gradually reduced over a period of weeks rather than stopping abruptly. This gradual tapering procedure is used to minimize potential reactions. The decision and procedure for discontinuation must be guided by a healthcare professional.

Advertisements

Recent Clinical Evidence

Research evidence / Overview of studies for Escitalopram Heumann

The research landscape for Escitalopram Heumann is built upon numerous official clinical evaluations, primarily Randomized Controlled Trials (RCTs), systematic reviews, and long-term follow-up studies. This overview describes the research contexts, the outcomes that studies monitored, and the areas where data remains limited, using only non-advisory, evidence-neutral language. Studies help show what has been observed so far, but findings describe group patterns, not personal outcomes.


Evidence for use in Mood and Generalized Anxiety

Research on Major Depressive Disorder (MDD)

Escitalopram was studied for use in conditions involving periods of heightened symptoms of Major Depressive Disorder (MDD) in a large number of short-term (typically 8 to 12 weeks) RCTs. Outcomes related to symptoms were consistently measured using standardized scales like the Montgomery-Asberg Depression Rating Scale (MADRS). Research also examined maintenance and relapse prevention, where patients were followed for extended periods to monitor the continuation of the measured change. Data for certain groups remain insufficient, and long-term effects beyond the maintenance phase are not fully established.

Research on Generalized Anxiety Disorder (GAD)

Research explored the use of this medicine in Generalized Anxiety Disorder (GAD) in short-term (8 to 12 weeks) RCTs in adults. Primary outcomes were measured using scales like the Hamilton Anxiety Rating Scale (HAM-A), focusing on symptom intensity. Longer studies were conducted to examine continuation of response. However, the systematic study of GAD beyond the initial 8-week acute phase evidence is limited, and data for specific comorbidities are not always robust.


Evidence in Specific Populations

Research was studied for use in specific age groups, including adolescents (12-17 years for MDD/GAD) and older adults. For adolescents with MDD, initial findings were mixed, though later re-analyses provided insight into short-term changes. For older adults, evidence suggests that measured change on cognitive and attentional tasks was observed in some studies. Data for certain groups, particularly children under age 7 for GAD and adolescents under age 12 for MDD, remain insufficient for analysis, and long-term effects in these younger groups are not fully established.


What is Still Uncertain About Escitalopram Heumann

While extensive controlled research exists, the evidence highlights what is known—and what is still uncertain. Follow-up durations were limited in many acute trials, meaning there is limited information for long-term outcomes and the sustained effects over several years. Certainty remains low regarding the effect patterns in patients with specific, complex medical comorbidities. Comparative evidence is lacking for a direct evaluation against all other available treatment options. Furthermore, research does not determine whether an individual will respond similarly to the group patterns observed in the studies.

Key Studies & References

  1. Escitalopram - StatPearls (General review of approved indications and use)
  2. Public Assessment Report Scientific discussion Escitalopram Bristol 5 mg, 10 mg, 15 mg and 20 mg film-coated tablets (EMA/National Agency Summary)
Advertisements

Frequently Asked Questions (FAQ)

Common questions about Escitalopram Heumann (FAQ)


Q: Is Escitalopram Heumann the same as Lexapro?

A: Escitalopram Heumann is a medicine containing the active substance escitalopram. Lexapro is a well-known brand name for a product with the same active ingredient. Therefore, both contain the same medicinal component, though they may differ in other inactive ingredients or branding.

Q: What is the main active ingredient in Escitalopram Heumann?

A: The main active ingredient in this medication is escitalopram. This component is responsible for the therapeutic effects described in the official product information.

Q: Does Escitalopram Heumann help with anxiety or just depression?

A: Official regulatory documents indicate that escitalopram is used to treat both major depressive disorder (MDD) and generalized anxiety disorder (GAD) in adults. Some sources also list its use for conditions like panic disorder.

Q: What are the official conditions Escitalopram Heumann is used to treat?

A: Escitalopram is officially indicated for treating major depressive disorder and generalized anxiety disorder. Additionally, official prescribing information may list other conditions such as obsessive-compulsive disorder (OCD) and panic disorder, depending on the authorized jurisdiction.

Q: What happens if I miss a dose of Escitalopram Heumann?

A: If a dose is missed, official patient guidance recommends taking it right away if remembered before bedtime. However, if it is remembered only the next day, official guidance describes skipping the missed dose and resuming the regular schedule. Regulatory guidance advises against taking a double dose.

Q: What are the most commonly reported side effects of Escitalopram Heumann?

A: According to official product information, very commonly reported side effects often include nausea, headache, and difficulty sleeping or sleepiness. Other common effects include dry mouth, increased sweating, and sexual problems. Side effects are often most noticeable when treatment is first started.

Q: Does Escitalopram Heumann typically cause weight gain or weight loss?

A: Changes in appetite are listed among the possible side effects reported in clinical studies. Because of this, patients may experience either weight gain or weight loss while using escitalopram.

Q: Is sexual dysfunction a common side effect of Escitalopram Heumann?

A: Sexual dysfunction is listed in regulatory documents as a common adverse reaction. This can include decreased libido or difficulties with orgasm or ejaculation.

Q: Do the common side effects of Escitalopram Heumann usually go away over time?

A: Official information indicates that common adverse events are usually described as mild and transient. These effects are typically reported to be most frequent and intense during the first two weeks of treatment, and often decrease with continued use.

Q: Is Escitalopram Heumann considered a sedating or activating medication?

A: Clinical trial data lists both sleepiness (somnolence) and difficulty sleeping (insomnia) as common adverse reactions. This suggests the medication can have different effects on sleep and alertness depending on the person.

Q: Can Escitalopram Heumann affect my ability to drive?

A: Official labeling advises that escitalopram may cause drowsiness and can affect a person's ability to make judgments or coordinate movements. Official labeling states that individuals should know how the medicine affects them before driving or operating machinery.

Q: Is it safe to take Escitalopram Heumann with other antidepressants?

A: Regulatory documents state that escitalopram must not be used with specific drug classes, such as Monoamine Oxidase Inhibitors (MAOIs), due to the high risk of a serious condition called Serotonin Syndrome. Caution is advised when used with other medicines that increase serotonin levels, which includes certain other antidepressants.

Q: Are there any herbal supplements that should be avoided with this medication?

A: The use of the herbal remedy St. John’s Wort (Hypericum perforatum) is specifically mentioned in official documents as a combination that should not be used. This is because it can heighten the risk of side effects, including Serotonin Syndrome.

Q: Can Escitalopram Heumann be used by children or adolescents?

A: In some jurisdictions, official product information includes an indication for treating major depressive disorder in pediatric patients 12 years of age and older. Treatment for this age group requires specialized medical supervision.

Q: Is Escitalopram Heumann appropriate for older adults?

A: Yes, regulatory information includes a specific recommended dosage for elderly patients, typically those over 65 years of age. Treatment in this population may require special consideration or dosage adjustment.

Q: What is known about using Escitalopram Heumann during pregnancy?

A: Using medications like escitalopram late in the third trimester of pregnancy has been associated in regulatory warnings with potential effects in the newborn. These include issues like persistent pulmonary hypertension of the newborn (PPHN) and other temporary difficulties adapting outside the womb. Use during pregnancy is a factor that requires careful consideration in a clinical setting.

Q: Is it safe to use Escitalopram Heumann while breastfeeding?

A: Escitalopram is known to pass into human breast milk. Official regulatory and informational bodies note that infants should be monitored for potential side effects such as increased drowsiness, restlessness, or difficulty feeding.

Q: Does Escitalopram Heumann have a risk of causing dependence?

A: The medication is not typically associated with the compulsive drug-seeking behavior of addiction. However, the body can adapt to its presence, which is why official guidance mandates that the dose be gradually reduced over a period of weeks when stopping treatment, to minimize potential discontinuation symptoms.

Q: What is the difference between Escitalopram and Citalopram?

A: Citalopram is a medication containing a mixture of two mirror-image molecules called enantiomers, the R- and S-enantiomers. Escitalopram is described in official product information as the purified S-enantiomer of citalopram, which is considered the therapeutically active part of the compound.

Q: Is it true that Escitalopram Heumann can increase the risk of suicidal thoughts?

A: Antidepressants, including escitalopram, carry a serious warning regarding the potential to increase the risk of suicidal thoughts and behavior in children, adolescents, and young adults (up to age 24). This risk is highest during the first few weeks of treatment or following dose adjustments.

Q: Can Escitalopram Heumann affect my sleep patterns?

A: Yes, official adverse event lists commonly include both insomnia (difficulty falling or staying asleep) and somnolence (drowsiness or sleepiness). These effects can manifest differently in various people.

Q: How long might I need to take Escitalopram Heumann before considering stopping?

A: Official patient guidance often notes that continued treatment for several months after symptoms improve is common, as this can help prevent a relapse. Official patient guidance notes that the duration of treatment is determined in consultation with a healthcare professional.

Q: Can Escitalopram Heumann cause confusion or memory issues?

A: Reported side effects include confusion, dizziness, and memory problems. These may be isolated effects or, in rare cases, could be part of a more serious adverse event like hyponatremia (low sodium levels).

Q: Is Escitalopram Heumann approved in my country (UK/US/EU example)?

A: The active ingredient, escitalopram, is approved and has official product documentation from major regulatory bodies worldwide, including the EMA (European Medicines Agency) and the FDA (U.S. Food and Drug Administration). The brand name 'Heumann' is typically authorized for use in the European Union.

Q: What are the reported withdrawal symptoms when stopping Escitalopram Heumann?

A: Discontinuation symptoms associated with stopping treatment may include mood changes, agitation, nausea, dizziness, tingling/prickling sensations, headache, sweating, and confusion. Regulatory guidance recommends a gradual reduction in dose to minimize the occurrence and severity of these reactions.

Q: Can taking Escitalopram Heumann cause a false positive on a drug test?

A: While some antidepressant medications have chemical structures that can potentially trigger a false positive result on certain drug screenings, escitalopram is generally not reported in authoritative medical literature to be a common cause of false positive results for other substances.

Q: Do I need to have blood tests while taking Escitalopram Heumann?

A: Routine blood tests are not typically mandated for all patients taking this medication. However, official information states that close monitoring, including blood tests, is required for patients taking warfarin or other blood thinners. Testing may also be necessary in cases of suspected adverse reactions or overdose.

Q: Is there any research on Escitalopram Heumann for pain conditions?

A: Escitalopram is not officially indicated for pain conditions. However, studies have been published in medical literature that examine its effect on pain severity or pain interference in individuals who also have depressive or anxiety symptoms.

Q: What should I do if I experience severe headaches while on Escitalopram Heumann?

A: While headaches are a common side effect, a severe or unusual headache may also be a symptom of a serious side effect, such as hyponatremia (low sodium levels in the blood). Official patient guidance stresses that severe or concerning symptoms should be discussed with a medical professional.

Q: Can Escitalopram Heumann cause stomach upset or nausea?

A: Nausea is listed as a very common side effect in clinical trials, and other gastrointestinal disturbances, such as diarrhea, are also frequently reported. These effects are often temporary and tend to improve over time.

Q: Does Escitalopram Heumann interact with common heart medications?

A: Regulatory documents list a strict contraindication against combining escitalopram with any medicinal product known to prolong the QT interval. This is a measure of heart rhythm, and the combination could lead to a rare but life-threatening heart rhythm issue.

Q: Can Escitalopram Heumann make me feel worse before I feel better?

A: Some individuals, especially those with panic disorder, may experience an initial increase in anxiety or agitation symptoms. Furthermore, the warning regarding increased suicidal thoughts is noted as being highest during the initial phase of treatment.

Q: Are there any known long-term effects of taking Escitalopram Heumann?

A: There are no reported problems associated with long-term use when taken as prescribed in regulatory guidance. However, official information notes that the need for continued therapy should be periodically assessed by a healthcare provider.

Q: Can Escitalopram Heumann cause or worsen tremors?

A: Tremor (involuntary rhythmic shaking) is listed in official product information as a potential side effect of escitalopram.

Q: Are there any genetic factors that influence how Escitalopram Heumann works?

A: Regulatory information describes that the breakdown of escitalopram in the body is partially managed by the CYP2C19 enzyme system. Individuals who have reduced activity in this enzyme (called 'poor metabolizers') are described as potentially having higher levels of the drug in their blood.

Q: Is Escitalopram Heumann commonly used for Panic Disorder?

A: While the primary indications are Major Depressive Disorder and Generalized Anxiety Disorder, official sources and prescribing information in many regions also include panic disorder as a condition for which escitalopram is used.

Q: Can I take Escitalopram Heumann if I have a history of bipolar disorder?

A: Official labeling recommends that patients should be screened for a history of bipolar disorder before starting treatment. For patients with this history, regulatory information describes the use of the medication with caution, and discontinuation is noted if they enter a manic episode.

Q: Does Escitalopram Heumann affect the body's salt levels?

A: Yes, official product information warns that escitalopram can cause hyponatremia, which means the level of sodium (salt) in the blood is too low. Symptoms can include headache, confusion, and difficulty concentrating.

Advertisements

How should Escitalopram Heumann be stored and disposed of?

Escitalopram Heumann: Official Storage and Disposal Instructions

Storage Requirements

Escitalopram tablets must be stored at Controlled Room Temperature, defined as 20 C to 25 C (68 F to 77 F), with permitted brief excursions up to 30 C. It is mandatory to keep the medicine in its original container to protect from moisture and excessive heat. The product must not be frozen. All forms of the medication must be stored out of the sight and reach of children to prevent accidental ingestion.

Disposal Instructions

Unused or expired Escitalopram must be disposed of in accordance with local requirements. The preferred regulatory method is using an official drug take-back program or authorized disposal service. If a take-back option is unavailable, the medication may be placed in the household trash after being mixed with an undesirable substance, but it should not be flushed down the toilet.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Escitalopram Heumann found in:

A-Z Index: